Powering Advancements in Heart Health
The ability to detect cardiac biomarkers at ultra-low levels is advancing the future of heart health.
Simoa® assays have the potential to detect cardiac biomarkers, which are instrumental for predicting major adverse cardiovascular events, development of heart failure or transition to end-stage kidney disease, earlier than ever before. Further, the ability to detect minute changes in these biomarkers could enable the identification of at-risk patients earlier in their disease progression to guide more personalized, preventive care.
Simoa® in Action
At the inaugural Powering Precision Health Summit, leading researchers discussed groundbreaking research in cardiology.